Abstract:BackgroundNebulised antibiotics are frequently used for the prevention or treatment of ventilator-associated pneumonia. Many factors may influence pulmonary drug concentrations with inaccurate dosing schedules potentially leading to therapeutic failure and/or the emergence of antibiotic resistance. We describe a research pathway for studying the pharmacokinetics of a nebulised antibiotic during mechanical ventilation using in vitro methods and ovine models, using tobramycin as the study antibiotic.MethodsIn vitro studies using a laser diffractometer and a bacterial-viral filter were used to measure the effect of the type and size of tracheal tubes and antibiotic concentration on the particle size distribution of the tobramycin 400 mg (4 ml; 100 mg/ml) and 160 mg (4 ml, 40 mg/ml) aerosol and nebulised mass delivered. To compare the regional drug distribution in the lung of two routes (intravenous and nebulised) of drug administration of tobramycin 400 mg, technetium-99m-labelled tobramycin 400 mg with planar nuclear medicine imaging was used in a mechanically ventilated ovine model. To measure tobramycin concentrations by intravenous and nebulised tobramycin 400 mg (4 ml, 100 mg/ml) administration in the lung interstitial space (ISF) fluid and blood of mechanically ventilated sheep, the microdialysis technique was used over an 8-h duration.ResultsTobramycin 100 mg/ml achieved a higher lung dose (121.3 mg) compared to 40 mg/ml (41.3 mg) solution. The imaging study with labelled tobramycin indicated that nebulised tobramycin distributed more extensively into each lung zone of the mechanically ventilated sheep than intravenous administration. A higher lung ISF peak concentration of tobramycin was observed with nebulised tobramycin (40.8 mg/l) compared to intravenous route (19.0 mg/l).ConclusionsThe research methods appear promising to describe lung pharmacokinetics for formulations intended for nebulisation during mechanical ventilation. These methods need further validation in an experimental pneumonia model to be able to contribute toward optimising dosing regimens to inform clinical trials and/or clinical use.

Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for pharmacokinetic analysis

Exhaled volatile organic compounds as markers for medication use in asthma

P-117 ASSESSING EXHALED BREATH CONDENSATE AS MINIMALLY INVASIVE MATRIX FOR LUNG-RELATED BIOMARKER ANALYSES

Studying drug excretion into exhaled breath aerosol - A workflow based on an impaction sampling device and LC-HRMS/MS analysis

Safety and success of exhaled breath condensate collection in asthma

Feasibility of Exhaled Breath Condensate on Measuring Antibiotic Distribution in Airway Surface Liquid

Exhaled Breath Condensate—A Non-Invasive Approach for Diagnostic Methods in Asthma

A research pathway for the study of the delivery and disposition of nebulised antibiotics: an incremental approach from in vitro to large animal models

Determination of salbutamol in human plasma and urine using liquid chromatography coupled to tandem mass spectrometry and its pharmacokinetic study.

Impaction-Based Exhaled Breath Sampling for Substance Monitoring: A Prospective Pilot Study (DrugXhale).

A Simple Method for the Study of Salbutamol Pharmacokinetics by Ion Chromatography with Direct Conductivity Detection.

The Implication of Biomarkers in Exhaled Breath Condensate of Chronic Obstructive Pulmonary Disease

Application of a Novel Collection of Exhaled Breath Condensate to Exercise Settings

Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease

Exhaled Breath Condensate As a Method of Sampling Airway Nitric Oxide and Other Markers of Inflammation.

Urinary Excretion Kinetics of Salbutamol and Its Sulfoconjugated Main Metabolite after Oral and Inhalative Administration of Racemic Salbutamol or Levosalbutamol

In Silico Investigation of Inhalation Condition Impacts on Hygroscopic Growth and Deposition of Salbutamol Sulphate in Human Airways

Development and method validation of a sampling technique for a reproducible detection of synthetic cannabinoids in exhaled breath using an in vitro pig lung model

Standardization of the collection of exhaled breath condensate and exhaled breath aerosol using a feedback regulated sampling device

An Efficient Low‐Cost Device for Sampling Exhaled Breath Condensate EBC

Correlation of theophylline levels in rat exhaled breath and lung tissue after its intravenous injection